Kroger (KR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
13 May, 2026Executive summary
Annual meeting scheduled for June 25, 2026, with virtual participation and voting options available for shareholders.
Key business includes election of 10 directors, advisory approval of executive compensation, ratification of auditors, approval of an amended long-term incentive plan, and a shareholder proposal on GHG emissions.
Strong financial performance in 2025 with 2.9% ID sales growth (excluding fuel) and $4.9B adjusted FIFO operating profit.
CEO transition occurred in 2025, with Ronald Sargent serving as interim CEO and Gregory Foran appointed as CEO in 2026.
Voting matters and shareholder proposals
Board recommends FOR all director nominees, executive compensation, auditor ratification, and the amended long-term incentive plan.
Board recommends AGAINST the shareholder proposal requesting a report on GHG emissions reductions, citing current efforts and challenges in Scope 3 measurement.
Shareholder proposal focuses on expanding GHG reduction disclosures, especially Scope 3 emissions.
Board of directors and corporate governance
Board consists of 10 nominees with diverse backgrounds, including four women and two racially/ethnically diverse members.
Board leadership includes a separate Chairman, CEO, and Lead Independent Director.
All committees are fully independent; annual board and committee self-assessments are conducted.
Board succession planning and refreshment are ongoing, with a focus on diversity and skills relevant to strategy.
Latest events from Kroger
- Annual meeting covers director elections, pay, auditors, and a GHG report proposal.KR
Proxy filing13 May 2026 - Adjusted EPS and operating profit rose, with robust eCommerce and share repurchases in 2025.KR
Q4 202628 Apr 2026 - Dividend raised, strong sales, and all shareholder proposals defeated at the annual meeting.KR
AGM 20253 Feb 2026 - Q1 sales and digital growth offset profit declines as guidance and merger focus remain.KR
Q1 20253 Feb 2026 - Q2 2024 delivered 1.2% sales growth, $0.93 EPS, and strong digital gains amid merger progress.KR
Q2 202520 Jan 2026 - Q3 digital and pharmacy gains offset lower fuel sales; Albertsons merger terminated, $7.5B buyback set.KR
Q3 202511 Jan 2026 - Strong 2024 sales and digital growth set the stage for further gains and capital returns in 2025.KR
Q4 20256 Jan 2026 - Q2 2025 delivered strong sales, margin growth, and raised guidance, led by eCommerce and pharmacy.KR
Q2 202615 Dec 2025 - Adjusted EPS rose 7% to $1.05, but a $2.6B impairment drove a net loss.KR
Q3 202612 Dec 2025